• linkedin
  • Increase Font
  • Sharebar

    Hypothermia during RARP: No significant benefit seen

    Single-surgeon study success not replicated in randomized controlled trial

    Although theory and preliminary clinical data indicated that intraoperative regional hypothermia could improve the return to potency and continence after robot-assisted radical prostatectomy (RARP), the intervention did not have any significant benefits when put to the more rigorous test of a randomized controlled trial.

    Results of the latter investigation, however, did underscore the critical role of surgeon skill in the post-RARP course of recovery, reported researchers from the University of California, Irvine (UCI), at the European Association of Urology annual congress in London.

    Also see: Is focal therapy the future of treatment for localized PCa?

    “Most single-surgeon studies report that advancing age is an independent factor for delaying return of continence and reducing overall continence rates following RARP, and it is believed that inflammation is the key mediator for these outcomes, with the presumption being that older men do not recover from the inflammation induced by surgical trauma as well as younger patients. The idea for regional hypothermia is to provide a local anti-inflammatory effect, and we found it had benefit in a single-surgeon study,” said Linda Huynh, BS, assistant research specialist in urology at UCI.

    “With further evaluation, however, in a multinational randomized controlled trial involving five high-volume surgeons recruited from outside of our institution, any potential benefit of hypothermia was overwhelmed by the consequences of significant individual surgeon outcome. These results are hypothesis-generating. They suggest that surgeon skill dwarfs the impact of anti-inflammatory action from regional hypothermia and that minimizing surgical trauma is much more effective than accepting the trauma and trying to preemptively prevent the inflammatory process with hypothermia,” Huynh added.

    The technology used for regional hypothermia during RARP was developed and patented by researchers in the UCI department of urology in 2009. It consists of an endorectal cooling balloon that circulates 4°C saline in the rectum to reduce the local tissue temperature to about 20°C during RARP.

    Read: Urologists positive about abiraterone integration

    Thomas Ahlering, MD, professor and vice chairman of urology at UCI, performed all of the procedures in the single-surgeon study. Young Hwii Ko, MD, a visiting research professor from Korea, was lead author of the study that included 930 non-high risk men who underwent nerve-sparing RARP. The population was comprised of two sequentially operated series, the first including 464 men who had a standard, normal thermic procedure and the next 466 who received regional hypothermia. All men had a minimum follow-up of 12 months post-RARP.

    Postoperative potency was defined by data from the 5-item International Index of Erectile Function (IIEF-5) questionnaire and required a score >17. Return of continence was defined as being pad-free. Outcomes were analyzed with men divided into two groups defined based on age and preoperative IIEF-5 scores. Group 1 included men aged <66 years with an IIEF score of 22-25. Group 2 was comprised of men who were aged ≥66 years or who were younger but had an IIEF-5 score of 17-21.

    Next: IIEF-5 score improvement observed


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available